Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains

被引:54
作者
Rodríguez-Hernández, MJ
Cuberos, L
Pichardo, C
Caballero, FJ
Moreno, I
Jiménez-Mejías, ME
García-Curiel, A
Pachón, J
机构
[1] Univ Hosp Virgen del Rocio, Infect Dis Serv, Seville 41013, Spain
[2] Univ Hosp Virgen del Rocio, Microbiol Serv, Seville 41013, Spain
关键词
D O I
10.1093/jac/47.4.479
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Sulbactam and imipenem were compared in an experimental pneumonia model in immunocompetent mice, using a susceptible strain of Acinetobacter baumannii, and in an experimental endocarditis model in rabbits, using an intermediately susceptible strain. In the former, sulbactam was as efficacious as imipenem in terms of survival, sterility of lungs and in the bacterial clearance from lungs and blood, provided that the t > MIC for sulbactam (1.84 h) was similar to that for imipenem (2.01 h). In the endocarditis model, imipenem (t > MIC, 2.12 h) was more efficacious than sulbactam (t > MIC, 1.17 h) in bacterial clearance from vegetations. These results show the efficacy of sulbactam in infections caused by susceptible strains of A. baumannii, with an MIC up to 4 mg/L, provided that doses reach a t > MIC similar to that of imipenem. The activity of sulbactam was time dependent.
引用
收藏
页码:479 / 482
页数:4
相关论文
共 13 条
[1]   Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii [J].
Corbella, X ;
Ariza, J ;
Ardanuy, C ;
Vuelta, M ;
Tubau, F ;
Sora, M ;
Pujol, M ;
Gudiol, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :793-802
[2]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[3]  
DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44
[4]   Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam [J].
JimenezMejias, ME ;
Pachon, J ;
Becerril, B ;
PalominoNicas, J ;
RodriguezCobacho, A ;
Revuelta, M .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) :932-935
[5]   BACTERICIDAL IN-VITRO ACTIVITY OF BETA-LACTAMS AND BETA-LACTAMASE INHIBITORS, ALONE OR ASSOCIATED, AGAINST CLINICAL STRAINS OF ACINETOBACTER-BAUMANNII - EFFECT OF COMBINATION WITH AMINOGLYCOSIDES [J].
JOLYGUILLOU, ML ;
DECRE, D ;
HERRMAN, JL ;
BOURDELIER, E ;
BERGOGNEBEREZIN, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (04) :619-629
[6]   ANTIMICROBIAL SUSCEPTIBILITIES OF CLINICAL ISOLATES OF ACINETOBACTER-BAUMANNII FROM SINGAPORE [J].
KUAH, BG ;
KUMARASINGHE, G ;
DORAN, J ;
CHANG, HR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2502-2503
[7]  
*NAT COMM CLIN LAB, 1992, 771E NCCLS
[8]  
National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS
[9]   INVITRO AND INVIVO ACTIVITIES OF SULBACTAM AND YTR830H AGAINST ACINETOBACTER-CALCOACETICUS [J].
OBANA, Y ;
NISHINO, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (05) :677-682
[10]  
PERLMAN BB, 1971, YALE J BIOL MED, V44, P206